Cases 21 - 30 of 46
H. LUNDBECK A/S et al v. APOTEX INC. et al
as 1:2020mc00032
Defendant:
LEK PHARMACEUTICALS D.D., MACLEODS PHARMA USA, INC., APOTEX INC. and others
Plaintiff:
TAKEDA PHARMACEUTICALS INTERNATIONAL AG, H. LUNDBECK A/S, TAKEDA PHARMACEUTICALS U.S.A., INC. (TPUSA) and others
Interested Party:
ANITA H CLAYTON
CASE NUMBER NOT USED
as 1:2020cv01371
Defendant:
LEK PHARMACEUTICALS D.D., MACLEODS PHARMA USA, INC., APOTEX INC. and others
Plaintiff:
TAKEDA PHARMACEUTICALS INTERNATIONAL AG, H. LUNDBECK A/S, TAKEDA PHARMACEUTICALS U.S.A., INC. (TPUSA) and others
Interested Party:
ANITA H CLAYTON
ACTELION PHARMACEUTICALS LTD et al v. MSN PHARMACEUTICALS INC. et al
as 1:2020cv03859
Defendant:
ZYDUS WORLDWIDE DMCC, MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED and others
Plaintiff:
NIPPON SHINYAKU CO., LTD. and ACTELION PHARMACEUTICALS LTD
Cause Of Action: 15 U.S.C. § 1126
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Alembic Pharmaceuticals Limited et al
as 1:2020cv00202
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Cadilla Healthcare Ltd. and others
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 1
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2020cv00074
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and Alembic Pharmaceuticals Limited
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2019cv02021
Defendant:
Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Global Holding SA and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals Limited et al v. GlaxoSmithKline LLC et al
as 1:2018cv01513
Plaintiff:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Defendant:
Glaxo Group Limited and GlaxoSmithKline LLC
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Alembic Pharmaceuticals Limited, et al
as 1:2018cv00113
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding S/A and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
